OpenVSafe by OpenVAERS
Search V-safe

CNB-14450-56788

2 vaccinations 5 coded responses 8 check-ins 5 free-text entries 4 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
902 / CA
Registered
2021-03-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-23
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-13
    Dose 2 — Pfizer-BioNTech
  3. 2021-03-01
    Registered in v-safe
  4. 2021-03-01
    Survey response — day 14, dose 2
    MedDRA: Dyspnoea exertional, Hypoaesthesia, Muscular weakness — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Bilateral numbness toes to saddle area, weakness in both legs; shortness of breath with mild exertion such as walking with walker support for 1 minute.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-06
    Survey response — day 21, dose 2
    MedDRA: Condition aggravated, Hypoaesthesia, Mobility decreased, Muscular weakness, Myelitis transverse, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Bilateral leg numbness and weakness, a regression of the transverse myelitis I had in acute stage October 2017. Residual deficit of impaired mobility had improved before my 2nd Pfizer vaccination on Feb. 13.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-06
    Report sent to call center — day 21, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2021-03-13
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  8. 2021-03-20
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  9. 2021-03-27
    Survey response — day 42, dose 2
    MedDRA: Hypoaesthesia, Muscular weakness — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Numbness and weakness in both legs.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-03-27
    Report sent to call center — day 42, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  11. 2021-05-15
    Survey response — 3 months, dose 2
    MedDRA: Condition aggravated, Dyspnoea, Hypoaesthesia, Muscular weakness, Pre-existing disease, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Increase of leg weaknesses and numbness causing shortness of breath and tachycardia. This noted relapse of transverse myelitis started after 2nd shot of Pfizer vaccine.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-05-15
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2021-08-14
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  14. 2022-02-13
    Survey response — 12 months, dose 2
    MedDRA: Acupuncture, Pre-existing disease — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Chronic pelvic pain · Healthcare visit (other): Acupuncture
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-02-13
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  16. 2022-02-15
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

DoseDateManufacturerCo-administered
12021-01-23Pfizer-BioNTech
22021-02-13Pfizer-BioNTech

Call center

4 call center cases

4 successful

See the call center timeline

Free text

Release 4 — day 14, dose 2

2021-03-01

Symptoms: Bilateral numbness toes to saddle area, weakness in both legs; shortness of breath with mild exertion such as walking with walker support for 1 minute.

Release 5 — day 21, dose 2

2021-03-06

Symptoms: Bilateral leg numbness and weakness, a regression of the transverse myelitis I had in acute stage October 2017. Residual deficit of impaired mobility had improved before my 2nd Pfizer vaccination on Feb. 13.

Release 6 — day 42, dose 2

2021-03-27

Symptoms: Numbness and weakness in both legs.

Release 8 — 3 months, dose 2

2021-05-15

Symptoms: Increase of leg weaknesses and numbness causing shortness of breath and tachycardia. This noted relapse of transverse myelitis started after 2nd shot of Pfizer vaccine.

Release 11 — 12 months, dose 2

2022-02-13

Symptoms: Chronic pelvic pain
Healthcare visit (other): Acupuncture

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOAcupuncture · · ✓
SDCondition aggravated ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDDyspnoea exertional ✓ ✓ ✓
SDHypoaesthesia ✓ ✓ ✓
SDMobility decreased ✓ ✓ ✓
SDMuscular weakness ✓ ✓ ✓
SDMyelitis transverse ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDTachycardia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release